ArticleDrugs2023

Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics.

Jeffrey CummingsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.